Barclays’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Barclays’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-60,000	Closed	-$2.04M	–	7530
2014 Q4	$2.04M	Sell	60,000 -60,400	-50%	-$1.97M	﹤0.01%	2520
2014 Q3	$3.49M	Buy	120,400 +100,300	+499%	+$2.13M	﹤0.01%	2127
2014 Q2	$402K	Sell	20,100 -9,200	-31%	-$211K	﹤0.01%	4179
2014 Q1	$791K	Sell	29,300 -7,400	-20%	-$196K	﹤0.01%	3495
2013 Q4	$734K	Buy	36,700 +24,800	+208%	+$468K	﹤0.01%	3720
2013 Q3	$214K	Sell	11,900 -658,300	-98%	-$11.9M	﹤0.01%	4974
2013 Q2	$11.1M	Buy	+670,200	New	+$10.7M	0.01%	1008

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's AUXL Position: Q1 2015 in Review

Barclays sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,128,949 shares — an estimated $38.4M sold.

Barclays first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $65.4M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Barclays reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 1,128,949 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $38.4M.
Barclays first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's AUXILIUM PHARAMCEUTICALS INC position peaked at $65.4M in Q3 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.